Extendicare Inc. (EXETF)
OTCMKTS · Delayed Price · Currency is USD
10.77
0.00 (0.00%)
Oct 6, 2025, 8:00 PM EDT
Extendicare Market Cap
Extendicare has a market cap or net worth of $901.50 million as of October 7, 2025. Its market cap has increased by 56.54% in one year.
Market Cap
901.50M
Enterprise Value
1.05B
Revenue
1.11B
Ranking
n/a
PE Ratio
14.78
Stock Price
$10.77
Market Cap Chart
Since May 15, 1997, Extendicare's market cap has decreased from 973.52M to 901.50M, a decrease of -7.40%. That is a compound annual growth rate of -0.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 892.19M | 44.68% |
| Dec 31, 2024 | 616.65M | 33.95% |
| Dec 29, 2023 | 460.35M | 11.06% |
| Dec 30, 2022 | 414.49M | -19.77% |
| Dec 31, 2021 | 516.64M | 10.73% |
| Dec 31, 2020 | 466.60M | -19.54% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |